Results for tag: "Critical Limb Ischemia Drug"

Critical Limb Ischemia (CLI) is a severe form of peripheral artery disease (PAD) that affects the lower extremities. It is caused by a narrowing of the arteries that supply blood to the legs, leading to a lack of oxygen and nutrients to the affected area. CLI can lead to severe pain, ulcers, and even amputation. The CLI drug market is a subset of the larger cardiovascular drug market. It is composed of drugs that are used to treat CLI, such as anticoagulants, antiplatelet agents, and vasodilators. These drugs are used to reduce the risk of further narrowing of the arteries, reduce pain, and improve blood flow to the affected area. The CLI drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and Novartis. Show Less Read more